If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Director/PDMR Shareholding

6 Jun 2012 16:25

RNS Number : 8348E
Harvey Nash Group PLC
06 June 2012
 

 

Harvey Nash Group plc

("the Company")

 

 

Harvey Nash Group plc

 

Grant of Options

On 1 June 2012 three Executive Directors were granted options in accordance with the rules of the Harvey Nash 2005 Executive Share Option Scheme (the 'Scheme'). Conditional awards were granted over ordinary shares of 5p each, at a price of £0.515 (the closing mid market price on 1 June 2012), as follows:

Director

Number of shares Awarded

Price per share

Balance of Conditional Awards

Albert Ellis

169,903

51.5p

929,903

Richard Ashcroft

84,951

51.5p

334,951

Simon Wassall

114,078

51.5p

717,021

 

Performance Criteria

 

Options are normally exercisable to the extent that the Company's compounded annual growth in Earnings Per Share (EPS) exceeds the compounded annual growth in the Retail Prices Index (RPI) by a minimum of 3% per annum over the performance period, which is three years from the date of grant.

 

Contact:

 

Richard Ashcroft, Group Finance Director - 020 7333 0033

 

 

6 June 2012

 

 

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSDFIMFESEEM
Date   Source Headline
1st Aug 20174:32 pmRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSTotal Voting Rights
28th Jul 20178:16 amRNSAdmission to AIM
28th Jul 20178:00 amRNSCancellation Harvey Nash Group PLC
3rd Jul 20172:24 pmRNSAcquisition of PAT Management AB
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20174:23 pmRNSDirector/PDMR Shareholding
29th Jun 20172:00 pmRNSSchedule 1 - Harvey Nash Group Plc
29th Jun 201712:49 pmRNSMove to AIM - Results of General Meeting
29th Jun 201712:49 pmRNSResults of Annual General Meeting
29th Jun 20177:00 amRNSAGM Statement
12th Jun 20177:00 amRNSBlock listing Interim Review
5th Jun 201712:35 pmRNSMove to AIM and notice of GM
2nd Jun 20175:26 pmRNSDirector/PDMR Shareholding
1st Jun 20177:00 amRNSTotal Voting Rights
31st May 20179:06 amRNSHolding(s) in Company
26th May 20174:57 pmRNSHolding(s) in Company
10th May 20175:07 pmRNSHolding(s) in Company
9th May 20174:00 pmRNSHolding(s) in Company
3rd May 20173:40 pmRNSHolding(s) in Company
3rd May 201711:30 amRNSDirector/PDMR Shareholding
2nd May 20177:00 amRNSTotal Voting Rights
28th Apr 20179:35 amRNSHolding(s) in Company
27th Apr 20177:00 amRNSDirectorate Change
27th Apr 20177:00 amRNSFinal Results
3rd Apr 201710:51 amRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSTotal Voting Rights
28th Mar 20175:01 pmRNSHolding(s) in Company
9th Mar 20177:00 amRNSAppointment of Group Finance Director
7th Mar 20175:04 pmRNSHolding(s) in Company
6th Mar 20175:21 pmRNSHolding(s) in Company
3rd Mar 20175:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20177:00 amRNSPre-close Trading Update and Notice of Results
1st Mar 20177:00 amRNSTotal Voting Rights
3rd Feb 201711:54 amRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSTotal Voting Rights
26th Jan 20175:50 pmRNSHolding(s) in Company
4th Jan 20173:55 pmRNSDirector/PDMR Shareholding
3rd Jan 20177:00 amRNSTotal Voting Rights
12th Dec 20167:00 amRNSBlock listing Interim Review
1st Dec 20167:00 amRNSTotal Voting Rights
30th Nov 20162:37 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSChange of Adviser
1st Nov 20167:00 amRNSTotal Voting Rights
27th Oct 20165:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20167:00 amRNSTotal Voting Rights
30th Sep 20165:19 pmRNSDirector/PDMR Shareholding
29th Sep 20167:00 amRNSUnaudited Half-year Results
5th Sep 20167:00 amRNSNotice of Results
1st Sep 20164:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.